abstract | Intestinal epithelial cells that line the mucosal surface of the gastrointestinal tract are positioned between an anaerobic lumen and a highly metabolic lamina propria. As a result of this unique anatomy, intestinal epithelial cells function within a steep physiologic oxygen gradient relative to other cell types. Furthermore, during active inflammatory disease such as IBD, metabolic shifts towards hypoxia are severe. Studies in vitro and in vivo have shown that the activation of hypoxia-inducible factor (HIF) serves as an alarm signal to promote the resolution of inflammation in various mouse models of disease. Amelioration of disease occurs, at least in part, through transcriptional upregulation of nonclassic epithelial barrier genes. There is much interest in harnessing hypoxia-inducible pathways, including stabilizing HIF directly or via inhibition of prolyl hydroxylase enzymes, for therapy of IBD. In this Review, we discuss the signaling pathways involved in the regulation of hypoxia and discuss how hypoxia may serve as an endogenous alarm signal for the presence of mucosal inflammatory disease. We also discuss the pros and cons of targeting these pathways to treat patients with IBD.
Introduction the intestinal epithelium lines the entire gastrointestinal tract, covering a surface area of approximately 300 m 2 in the adult human and forming an essential barrier to the outside world. this intestinal epithelial barrier consists of a monolayer of cells with intercellular tight junctions, a complex three-dimensional structure and a thick mucous gel layer secreted by the mucous membrane, and provides a dynamic and regulated barrier to the flux of the luminal contents to the lamina propria.
1,2 as well as having an important role in nutrient uptake and the development of oral tolerance to nonpathogenic antigens, the intestinal epithelial barrier drives the daily absorption of at least 9 l of fluid. Both the absorptive and barrier functions of the intestinal epithelium are regulated by the availability of oxygen. 3 it is widely understood that the gastrointestinal tract functions in a state of low-grade inflammation. such a state results from the constant processing of luminal antigenic material during the development of oral tolerance and the priming of the mucosal immune system for rapid and effective responses to antigens or microbes that may penetrate the barrier.
the anatomy and function of the intestine provide a fascinating oxygenation profile as, even under physiologic conditions, the intestinal mucosa experiences profound fluctuations in blood flow and metabolism. For example, less than 5% of total blood volume is present in the gut during fasting, but, following ingestion of a meal, approximately 30% of total blood volume is found in the gut. such changes in blood flow also result in marked shifts in local oxygen partial pressure. notably, there is a steep oxygen gradient from the anaerobic lumen of the intestine, across the epithelium and into the highly vascularized subepithelium. From this perspective, it is perhaps not surprising that the epithelium has evolved a number of features to cope with this metabolic setting. in fact, studies comparing functional responses between epithelial cells from different tissues have revealed that intestinal epithelial cells seem to be uniquely resistant to hypoxia and that an extremely low level of oxygenation within the normal intestinal epithelial barrier (so-called physiologic hypoxia) might be a regulatory adaptation mechanism to the steep oxygen gradient. 4 loss of epithelial barrier function with the resultant unrestricted flux of luminal antigens to the mucosal immune system underlies the pathology of iBD, and results in hypoxia within the chronically inflamed mucosa, particularly within the epithelial cell layer. ongoing studies suggest that hypoxia-regulated pathways are highly associated with iBD and contribute to the resolution of ongoing inflammation. in this review we discuss the signaling pathways involved in these processes and the possibility of developing therapies to modify the hypoxic state for the treatment of iBD.
Hypoxia and the immune response sites of mucosal inflammation are characterized by profound changes in tissue metabolism, including local depletion of nutrients, imbalances in tissue oxygen supply and demand, and the generation of large quantities of reactive nitrogen and oxygen intermediates. 3 in part, these changes can be attributed to the recruitment of inflammatory cells, including myeloid cells such as polymorphonuclear cells (Pmns; neutrophils) and monocytes ( Figure 1 ). Pmns are recruited by chemical signals, such as the chemokine interleukin 8, complement factor C5a, N-formylated peptides, platelet-activating factor and leuko triene B4, which are generated at sites of active inflammation as part of the innate host immune response to microorganisms. in transit, these cells expend tremendous amounts of energy. For instance, large amounts of atP are needed for the high actin turnover required for cell migration. 5 once at the sites of inflammation, the nutrient, energy and oxygen demands of the Pmns increase to accomplish the processes of phagocytosis and microbial killing. it has long been known that Pmns are primarily glycolytic cells, with few mitochondria and little energy produced by respiration. 6 a predominantly glycolytic metabolism ensures that Pmns can function at (Figure 1) . 7 ros are produced by phagocytes in a powerful oxidative burst, driven by a rapid increase in oxygen uptake and glucose consumption, which in turn triggers further generation of ros. when activated, it is estimated that Pmns can consume up to 10 times more oxygen than any other cell in the body. notably, the Pmn oxidative burst is not hindered by even relatively low oxygen concentrations (as low as 4.5%), 8 which is important, as it means that ros can be generated in the relatively low oxygen environments of inflamed intestinal mucosa. 3 in contrast to the innate immune response associated with Pmns, adaptive immune responses to inflammation in the intestine are characterized by a combination of recruitment of t cells and B cells and high rates of local t-cell and B-cell proliferation. as a result, adaptive immune responses have markedly different demands for glucose, oxygen and atP. 9, 10 in the past 10 years we have begun to understand the nature of the interactions between microenvironmental metabolic changes and the generation of recruitment signals and molecular mechanisms of leukocyte migration into these areas. the metabolic changes that occur as a result of the recruitment and activation of leukocytes during inflammation provide information about the potential sources of hypoxia at the intestinal epithelial barrier (Figure 1) .
iBD is an interesting disease for studying the metabolic changes associated with inflammation, particularly the development of hypoxia within inflammatory lesions. 3 some microvascular abnormalities that occur in patients with iBD have been associated with abnormal blood flow to the intestine, including increased production of tissue vasoconstrictor molecules and reduced generation of nitric oxide by endothelial cells, 11 as well as vascular endothelial growth factor (veGF)-dependent angiogenesis. 12 in addition, studies of active inflammation in mouse models of iBD have shown the intestinal epithelial cell to be particularly susceptible to hypoxia. 13 the presence of hypoxia in areas of inflammation in mouse models of iBD was first identified using 2-nitroimidazole dyes, a class of compounds known to undergo intracellular metabolism depending on tissue oxygenation ( Figure 2 ).
14 two important observations were made following tissue staining with these dyes in the mouse models of iBD. First, in the normal intestinal epithelial cells, especially those in the colon, physiologic hypoxia predominated ( Figure 2 ). whether such low oxygen levels function to regulate basal gene expression in the intestinal epithelial cells is not known. second, the inflammatory lesions seen in the mouse models were profoundly hypoxic or even anoxic, similar to that seen in some large tumors, and penetrated deep into the mucosal tissue. it is likely that there are multiple contributing reviews factors that predispose the inflamed intestinal epithelia to decreased oxygen delivery and hypoxia, such as vasculitis, vasoconstriction, edema and increased oxygen consumption ( Figure 1 ). 13 while 2-nitroimidazole compounds have not yet been used to image inflammatory lesions in patients with iBD, they are used clinically for tumor imaging and in the identification of stroke regions within the brain. 15 studies are also underway to use these compounds as radiosensitizers to enhance the efficacy and targeting of chemotherapy. 16 imaging techniques using these compounds have an advantage compared with other imaging techniques, in that they only allow imaging of viable tissue as the compounds are not active within apoptotic or necrotic regions. 17 Hypoxia-inducible factor the original study that identified the existence of inflammation-related hypoxia also showed that expression of hypoxia-inducible factor (HiF)1 is induced in the inflammatory lesions. 13 many cell types, including intestinal epithelial cells, 18 express both HiF1 and HiF2. evidence from mouse knockout studies that suggests that these proteins have nonredundant roles has been reviewed elsewhere. 19 some studies in mice have indicated that distinct transcriptional responses mediated by Hif1 and Hif2 may be integrated in ways that support particular adaptations to hypoxia. For example, the trans criptional responses that coordinate the glycolytic pathways include more than 11 target genes and seem to be more selective for the Hif1α than for the Hif2α isoform. 19 the selectivity of these two isoforms for the induction of erythro poietin expression, suggests a more important role for the HiF1α isoform. 19 Currently, this specificity is not well understood. the binding of Hif1α or Hif2α to different transcription factors at the site of Dna binding could determine such specificity, 19 but the evidence for this is not conclusive. several studies have shown that HiF1 triggers the transcription of many genes that enable intestinal epithelial cells to act as an effective barrier. 4, [20] [21] [22] originally
shown by microarray analysis of hypoxic intestinal epithelial cells, 21 these studies have been validated in animal models of intestinal inflammation 13, [23] [24] [25] [26] [27] and in inflamed intestinal tissues in humans. [28] [29] [30] the functional proteins encoded by hypoxia-induced, HiF-dependent messenger rnas (mrnas) localize primarily to the most luminal aspect of polarized epithelia. 4, 20, 21 molecular studies of these hypoxia-elicited pathways have shown a dependence on HiF-mediated transcriptional responses. 4, 20, 21 notably, pathways driven by HiF that protect the intestinal epi thelial barrier tend not to be the classic regulators of barrier function, such as the tight junction proteins occludin or claudin. rather, the HiF-dependent pathways are more to do with overall tissue integrity, ranging from increased mucin production 31 by molecules that modify mucins, such as intestinal trefoil factor, 4 to xenobiotic clearance by P-glycoprotein, 20 to nucleotide metabolism by 5'-nucleotidase, ecto (nt5e; CD73) 21, 22 and nucleotide signaling through the adenosine a 2B receptor. 22 as an extension of the original studies identifying induction of HiF expression within the intestinal mucosa, Karhausen et al. generated transgenic mice expressing either mutant Hif1α (which is unable to form Hif1) or mutant von Hippel-lindau gene (leading to forma tion of constitutively active Hif1) targeted to the intestinal epithelial cells. 13 loss of epithelial Hif1α expression resulted in a more severe colitic phenotype than found in animals with wild-type Hif1α, with increased weight loss, decreased colon length and increased epi thelial permeability. By contrast, constitutively active intestinal epithelial Hif1 was protective for these parameters. these findings may be somewhat model dependent, as epithelial Hif1-based signaling has also been shown to promote inflammation in one study. 27 However, the findings do confirm that intestinal epithelial cells can adapt to hypoxia and that HiF may contribute to this.
nonepithelial cell types within the gastro intestinal mucosa have also been studied for HiF expression and their response to hypoxia. activated t cells show reviews increased expression of HiF1α, which prevents them from undergoing activation-induced cell death in hypoxic settings. t-cell survival in hypoxia is, at least in part, mediated by the vasoactive peptide adreno medullin. 32 other studies using chimeric mice bearing HiF1α-deficient t and B cells have revealed lineage-specific defects that result in increased levels of auto immunity, including autoantibodies, increased rheumatoid factor and kidney damage. 10 HiF function has also been studied in some detail in myeloid cells. Cre-LoxP-based elimination of Hif1α in cells of the myeloid lineage has revealed multiple features that implicate HiF1α in the metabolic control of myeloid function, and the details of this have been reviewed elsewhere. 33 in particular, these studies have shown that the capacity of Pmns and macrophages to kill bacteria is severely limited in the absence of HiF1α, as HiF1α is central to the production of antimicrobial peptides and granule proteases. these findings are explained, at least in part, by the inability of myeloid cells to mount appropriate metabolic responses to the decreased oxygen concentrations that are character istic of sites of infection. 33 Finally, compelling evidence has shown that HiF1α controls the transcription of the integrin gene that is crucial for all myeloid cell adhesion and transmigration, namely β2 integrin. 34, 35 such findings help us to understand the role of functional Pmns in iBD. For example, Pmn depletion techniques have been used to show a central role for Pmns in the resolution of inflammation in several mouse models of iBD. 36 
Stabilization of hypoxia-inducible factor
in the past 10 years, the molecular mechanisms of HiF stabilization have been clarified. Four HiF hydroxylases-prolyl hydroxylase (PHD) 1, 2 and 3 (also known as egl nine homolog 1, 2 and 3) and factor inhibiting HiF1 (FiH1)-have been shown to be important in the hypoxic regulation of the HiF pathway. 37 each of these hydroxylases is encoded by a different gene and each enzyme has a tissue-specific expression pattern. 37 all three PHDs and FiH are found in the intestinal epithelium. 23, 26, 38 markedly different phenotypes are found in mice that lack the individual isoforms of these hydroxylases. For instance, Phd1 homozygous knockout mice have a reprogrammed basal metabolic profile in normal tissue that decreases exercise performance but protects against acute liver and muscle ischemia. 39 ,40 the homozygous knockout of Phd2 is embryonic lethal due to developmental angiogenesis dysfunction, 41, 42 and Phd2 heterozygous knockout mouse models of cancer have enhanced tumor angiogenesis but decreased metastasis. 41 Phd3 homozygous knockout mice have reduced neuronal apoptosis, abnormal sympatho adrenal system development and reduced blood pressure. 43 these diverse phenotypes strongly suggest that these enzymes have distinct isoform-specific functions in vivo.
in the presence of 2-oxoglutarate, iron and oxygen, PHDs hydroxylate the α subunit of HiF1 leading to directed ubiquitylation and subsequent degradation of HiF1. 37 PHDs act on prolines 402 and 564 within the oxygen-dependent degradation domain (oDD) of the HiF1α subunit. [31] [32] [33] [34] the oDD domain contains two subdomains, C-oDD and N-oDD, which contain prolines 402 and 564, respectively, within a lXXlaP motif (Figure 3) . 36 Hypoxia or pharmacologic agents, such as dimethyloxaloylglycine (DmoG), inhibit the HiF hydroxylases, thereby leading to derepression of HiF by preventing its degradation. the impact of such HiF hydroxylase inhibitors on epithelial cell gene expression is not restricted to regulation via HiF. For example, nFκB is regulated by HiF hydroxylases (discussed below). 37 45 likewise, nFκB is thought to be largely protective in the intestinal epi thelium as it inhibits apoptosis of enterocytes, which leads to improved functioning of the intestinal epi thelial barrier. 23 Convergence of inflammation and hypoxia the oxygen-dependent regulatory role of PHDs might not be restricted to the HiF pathway and this additional role may allow better understanding of how hypoxia contributes to other aspects of inflammation. For instance, as mentioned above, nFκB may interact with the HiF pathway and it is activated during inflammation. nFκB consists of either homodimers or heterodimers and, on activation, translocates to the nucleus and binds to the transcriptional p300-CBP coactivator family to activate or repress transcription of various genes. 44 the activity of nFκB is regulated by the inhibitory iκB proteins. reviews the best studied complex is iκBα bound to the nFκB p50-p65 dimer. 46 the interaction with iκBα inhibits nFκB from binding to Dna and maintains the complex in the cytoplasm. on activation by various extracellular signals, iκB kinase (iKK) phosphorylates iκBα, 47 which is then polyubiquitylated. 48 the polyubiquitylated iκBα is then selectively degraded by the s26 proteasome. once dissociated from iκBα, nFκB rapidly enters the nucleus and activates gene transcription.
it is now appreciated that nFκB-dependent pathways are also regulated by PHDs and that PHD inhibitors also target and produce their effects in mouse models of colitis via the nFκB pathway. indeed, hypoxia has been shown to activate nFκB and this seems, at least in part, to be dependent on PHD-mediated hydroxylation of iKKβ. 38, 49 in normoxia, iKKβ activity is held in check through lXXlaP-dependent hydroxylation by PHD1 and PHD2. 38 it is notable that conditional deletion of the nFκB pathway in intestinal epithelial cells in mice leads to an increased susceptibility to colitis, 50 similar to that of mice expressing homozygous mutant Hif1α. 13 this implicates epithelial nFκB in a predominantly protective role in colitis, probably through the expression of anti-apoptotic genes in intestinal epithelial cells and through enhanced epithelial barrier function. 23 it has been suggested that both the HiF and nFκB pathways may also be influenced by mediators found within inflammatory sites, including microbial products, cytokines and even intact bacteria. 33 nFκB is a classic transcriptional regulator activated by a spectrum of agonists, which drive a complex series of receptormediated signaling pathways. it has been indicated that trans cription of HIF1α is activated by nFκB-mediated signaling. 51 inflammation-associated upregulation of Hif1α mrna occurs in an nFκB-dependent manner. 51 it also seems that increased nFκB activity in hypoxia can be regulated by Hif1, 44 thus a cross-regulatory loop may exist between these two pathways and may involve other transcriptional regulators that bear nonredundant PHD sensitivity, including activating transcription factor 4 (atf4) and notch, 52, 53 which are both important regulators of cell fate (Figure 4) . Given that intestinal epithelial cells are in an environ ment in which there is constant exposure to potentially inflammatory stimuli, the crossregulation of HiF and nFκB may have profound implications for intestinal epithelial cell function and survival under both homeostatic and disease conditions.
Therapies for IBD
the finding that hypoxia serves as an alarm signal to promote the resolution of inflammation in iBD holds promise for the development of therapies for this disease that target hypoxia pathways. although preclinical studies have focused primarily on the use of PHD inhibitors in mouse models of acute colitis, the ultimate goal should be the development of viable therapies for active, chronic intestinal inflammation.
the identification of HiF-selective PHDs has provided unique opportunities for the development of PHD-based therapies. 54, 55 there is wide interest in developing HiF1 inhibitors as potential cancer therapies, but opportunities also exist to selectively stabilize HiF in an attempt to support mucosal barrier function and promote inflamma tory resolution in patients with iBD. one approach that we have taken is to stabilize HiF through the use of PHD inhibitors. 26 For example, 2-oxoglutarate analogues can stabilize HiF1α. 54 this approach is not selective for particular PHD isoforms. However, some in vitro studies suggest that marked differ ences in substrate specificity may exist and could be harnessed for selectivity, and this possibility has been reviewed elsewhere. 37 For example, all PHDs hydroxylate the C-oDD domain more efficiently than the N-oDD domain (Figure 3) , and PHD2 hydroxylates the N-oDD domain of HiF2α less efficiently than the N-oDD domain of HiF1α. 37 in addition, PHD3 does not hydroxylate the N-oDD domain of HiF1α. 56, 57 it is also likely that the protection afforded by PHD inhibitors (for example, decreased levels of tissue inflammatory cytokines, improved barrier function and decreased amounts of epithelial cell apoptosis) may involve both HiF and nFκB activities (Figure 4) . reviews several PHD inhibitors have been described, including direct inhibitors. 58 in addition, analogues of naturally occurring cyclic hydroxamates 59 and antagonists of α-ketoglutarate 54 are competitive inhibitors of PHDs (Figure 3) . within the gastrointestinal tract, the PHD inhibitors DmoG and FG-4497 have been used effectively to reduce symptoms in at least two mouse models of colitis. 23, 26 indeed, these studies have shown that both DmoG and FG-4497 provide an overall beneficial influence on multiple parameters studied in mice in which colitis was chemically induced with trinitrobenzene sulfonic acid (tnBs) or dextran sodium sulfate (Dss). in these mouse models, the drugs were well tolerated and there were no major adverse effects. in our experience, both FG-4497 and DmoG can be administered by multiple routes-intraperitoneal, oral and intravenous. 26 Both are absorbed orally with only a slight loss of efficacy compared with intraperitoneal administration. to date, no trials of DmoG or FG-4497 have been initiated for the treatment of iBD.
two notes of caution are worthy of discussion when considering the use of compounds that stabilize HiF, such as PHD inhibitors, as potential therapies. First, this class of drugs substantially raises hematocrit through increased erythropoietin production. in fact, given the central role of HiF-mediated signaling on erythropoietin production, PHD inhibitors are already in clinical trials for the treatment of anemia. 60 in our initial studies with mouse models of colitis, we observed that high doses of FG-4497 (>60 mg/kg) with five daily intervals of dosing resulted in occasional vascular occlusion within the intestine (s. P. Colgan and C. t. taylor, unpublished work). these adverse effects probably resulted from erythrocyte aggregation due to high hematocrits. this problem was rectified by lowering the dose and decreasing the interval of dosing. 26 as a second precautionary note, long-term stabilization of both HiF1 and HiF2 has been associated with a number of cancers. 61 whether pharmacological HiF stabilization could initiate or promote tumor develop ment is not known but should be considered as a potentially serious adverse effect of these drugs. until proven otherwise, the safest use of PHD inhibitors may be for short-term treatment of iBD or as an adjunct therapy with other drugs over a short time period.
Conclusions
the gastrointestinal mucosa is an interesting tissue in which to investigate tissue oxygenation and diseasebased metabolism. as outlined, there is evidence for hypoxia as an important alarm signal to promote the resolution of inflammation within the intestinal mucosa. Cultured cell systems, animal models and patient-derived materials have all been used to show that hypoxia is a significant component of the inflammatory microenvironment. likewise, studies in animal models of intestinal inflamma tion have demonstrated an almost uniformly beneficial influence of HiF stabilization on disease outcomes. it should be noted that the increased susceptibility to colitis following the deletion of Hif1 in intestinal epithelial cells may be somewhat model dependent and will require additional validation with PHD inhibitors before clinical studies can be implemented. ongoing studies to define the differences and similarities between innate and adaptive immune responses will continue to teach us important lessons about the complexity of the gastrointestinal tract. such information will provide new insights into the pathogenesis of iBD and, importantly, will provide new targets for the development of therapies for iBD.
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